Fertin Pharma A/S has just been awarded “Best Innovation 2018” for the development and commercialization of a product launched by our customer Johnson & Johnson in the autumn of 2018. The product has been developed and launched through a close and rewarding partnership with Johnson and Johnson. The award is given every year by Johnson & Johnson to a carefully selected supplier.
Johnson & Johnson has an annual revenue of approx. DKK 500 billion, is involved in a huge number of innovations per year and has a large number of suppliers in their portfolio. Therefore, this recognition is really great, and something Fertin is very proud of sharing!